Eli Lilly and Company

NYSE-LLY

OverviewFinancialsInvestor RelationsResearchEstimatesNewsOwnershipIndustryDividendsModelingFilings

Assets	LTM	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
Cash and Cash Equivalents	9,791.9	3,268.4	2,818.6	2,067	3,818.5	3,657.1	2,337.5	7,320.7	6,536.2	4,582.1	3,666.4
Cash and Cash Equivalents
Short-Term Investments	121.6	154.8	109.1	144.8	90.1	24.2	101	88.2	1,497.9	1,456.5	785.4
Short-Term Investments
Total Cash and Cash Equivalents	9,913.5	3,423.2	2,927.7	2,211.8	3,908.6	3,681.3	2,438.5	7,408.9	8,034.1	6,038.6	4,451.8
Accounts Receivable	16,107.4	11,005.7	9,090.5	6,896	6,672.8	5,875.3	4,547.3	4,593.9	4,546.3	4,029.4	3,513
Accounts Receivable, Net
Other Receivables	3,349.8	2,269.7	2,245.7	1,662.9	1,454.4	1,053.7	994.2	1,182.9	715.9	736.9	558.6
Other Receivables
Total Trade Receivables	19,457.2	13,275.4	11,336.2	8,558.9	8,127.2	6,929	5,541.5	5,776.8	5,262.2	4,766.3	4,071.6
Inventories	12,180.4	7,589.2	5,772.8	4,309.7	3,886	3,980.3	3,190.7	3,098.1	4,458.3	3,561.9	3,445.8
Inventories
Other Current Assets	20,520.2	8,451.9	5,690.3	2,954.1	2,530.6	2,871.5	2,538.9	4,265.8	1,447.5	734.6	604.4
Deferred Income Taxes
Prepaid Expenses and Other
Current Assets of Discontinued Operations
Prepaid Expenses
Other Current Assets
Total Current Assets	62,071.3	32,739.7	25,727	18,034.5	18,452.4	17,462.1	13,709.6	20,549.6	19,202.1	15,101.4	12,573.6
Total Current Assets
Net Property, Plant & Equipment	22,316	17,102.4	12,913.6	10,144	8,985.1	8,681.9	7,872.9	7,996.1	8,826.5	8,252.6	8,053.5
Property and Equipment, Net
Net Intangible Assets	6,446.7	6,166.3	6,906.6	7,206.6	7,691.9	7,450	6,618	1,068	4,029.2	4,357.9	5,034.8
Other Intangibles, Net
Goodwill	5,898	5,770.3	4,939.7	4,073	3,892	3,766.5	3,679.4	1,366.6	4,370.1	3,972.7	4,039.9
Goodwill
Goodwill and Other Intangibles, Net
Long-Term Investments	2,808.3	3,215.9	3,052.2	2,901.8	3,212.6	2,966.8	1,962.4	2,005.4	5,678.8	5,207.5	3,646.6
Investments
Other Long-Term Assets	15,395.1	13,720.3	10,467.2	7,129.9	6,572	6,305.8	5,443.8	10,922.7	2,874.3	1,913.8	2,220.5
Deferred Tax Assets
Prepaid Pension
Restricted Cash
Sundry
Other Noncurrent Assets
Noncurrent Assets of Discontinued Operations
Total Assets	114,935.4	78,714.9	64,006.3	49,489.8	48,806	46,633.1	39,286.1	43,908.4	44,981	38,805.9	35,568.9
Total Assets

Liabilities	LTM	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
Accounts Payable	4,262.2	3,228.6	2,598.8	1,930.6	1,670.6	1,606.7	1,405.3	1,207.1	1,410.7	1,349.3	1,338.2
Accounts Payable
Accrued Expenses	1,965.7	2,093.9	1,650.4	1,059.8	958.1	997.2	915.5	955.6	997.9	896.9	967
Employee Compensation
Short-Term Debt	1,633	5,117.1	6,904.5	1,501.1	1,538.3	8.7	1,499.3	1,102.2	3,706.6	1,937.4	6.1
Short-Term Borrowings and Current Maturities of Long-Term Debt
Other Current Liabilities	32,280	17,937	16,139.5	12,646.7	10,885.7	9,869	7,955.1	8,623.2	8,420.7	6,803	5,918.3
Sales Rebates and Discounts
Dividends Payable
Short-Term Income Taxes Payable
Deferred Income Taxes
Other Current Liabilities
Current Liabilities of Discontinued Operations
Total Current Liabilities	40,140.9	28,376.6	27,293.2	17,138.2	15,052.7	12,481.6	11,775.2	11,888.1	14,535.9	10,986.6	8,229.6
Total Current Liabilities
Long-Term Debt	40,873.6	28,527.1	18,320.8	14,737.5	15,346.4	16,586.6	13,817.9	9,196.4	9,940.5	8,367.8	7,972.4
Long-Term Debt
Other Long-Term Liabilities	10,070.1	7,539.6	7,528.6	6,838.7	9,252.1	11,739.7	10,993.9	11,914.8	8,836.7	5,371	4,776.6
Accrued Retirement Benefits
Long-Term Income Taxes Payable
Deferred Tax Liabilities
Noncurrent Liabilities of Discontinued Operations
Other Noncurrent Liabilities
Total Long-Term Liabilities	50,943.7	36,066.7	25,849.4	21,576.2	24,598.5	28,326.3	24,811.8	21,111.2	18,777.2	13,738.8	12,749
Total Noncurrent Liabilities
Total Liabilities	91,084.6	64,443.3	53,142.6	38,714.4	39,651.2	40,807.9	36,587	32,999.3	33,313.1	24,725.4	20,978.6

Equity	LTM	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
Common Stock	591.4	592.4	593.6	594.1	596.3	598.2	598.8	661	687.9	688.5	691.3
Common Stock
Issued Shares
Treasury Stock	-62.5	-49.5	-44.2	-50.5	-52.7	-55.7	-60.8	-69.4	-75.8	-80.5	-90
Cost of Common Stock in Treasury
Less Cost of Common Stock in Treasury
Additional Paid-in Capital	7,231.9	7,439.3	7,250.4	6,921.4	6,833.4	6,778.5	6,685.3	6,583.6	5,817.8	5,640.6	5,552.1
Additional Paid-in Capital
Accumulated Other Comprehensive Income	-6,219.5	-7,335.1	-7,340.2	-6,857.8	-7,356.3	-9,509.6	-9,536.8	-8,742.4	-8,731.8	-8,287.2	-7,593.9
Accumulated Other Comprehensive Loss
Employee Benefit Trust
Deferred Costs-Esop
Retained Earnings	22,252	13,545	10,312.3	10,042.6	8,958.5	7,830.2	4,920.4	11,395.9	13,894.1	16,046.3	16,011.8
Retained Earnings
Total Common Shareholders' Equity	23,793.3	14,192.1	10,771.9	10,649.8	8,979.2	5,641.6	2,606.9	9,828.7	11,592.2	14,007.7	14,571.3
Total Eli Lilly and Company Shareholders' Equity
Minority Interests and Other	57.5	79.5	91.8	125.6	175.6	183.6	92.2	1,080.4	75.7	72.8	19
Noncontrolling Interests
Total Shareholders' Equity	23,850.8	14,271.6	10,863.7	10,775.4	9,154.8	5,825.2	2,699.1	10,909.1	11,667.9	14,080.5	14,590.3
Total Equity
Total Liabilities and Shareholders' Equity	114,935.4	78,714.9	64,006.3	49,489.8	48,806	46,633.1	39,286.1	43,908.4	44,981	38,805.9	35,568.9
Total Liabilities and Equity